Apathy In Neurodegenerative Disorders clinical trials

Explore recruiting apathy in neurodegenerative disorders clinical trials.

Recruiting apathy in neurodegenerative disorders studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Apathy In Neurodegenerative Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A prospective, single-centre, randomised, double-blind, placebo-controlled, phase I, First-In-Human (FIH) trial evaluating the safety and tolerability of single and multiple ascending oral doses of IRL757 in healthy volunteers.

Sweden

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A single-centre, open-label, phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

Apathy In Neurodegenerative Disorders trials by city

Apathy In Neurodegenerative Disorders in Toronto Apathy In Neurodegenerative Disorders in Vancouver Apathy In Neurodegenerative Disorders in Montreal Apathy In Neurodegenerative Disorders in Calgary Apathy In Neurodegenerative Disorders in Edmonton Apathy In Neurodegenerative Disorders in Ottawa Apathy In Neurodegenerative Disorders in Winnipeg Apathy In Neurodegenerative Disorders in Quebec City Apathy In Neurodegenerative Disorders in Hamilton Apathy In Neurodegenerative Disorders in Kitchener Apathy In Neurodegenerative Disorders in London Apathy In Neurodegenerative Disorders in Halifax Apathy In Neurodegenerative Disorders in New York Apathy In Neurodegenerative Disorders in Los Angeles Apathy In Neurodegenerative Disorders in Chicago Apathy In Neurodegenerative Disorders in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease